The Clear Labels Act Would Change What You Know About Your Prescription Medication

ProPublicaCenter-LeftEN 5 min read 100% complete by Debbie CenziperFebruary 6, 2026 at 11:00 AM

AI Summary

long article 5 min

The Clear Labels Act, introduced by Senators Rick Scott and Kirsten Gillibrand, aims to increase transparency in the prescription drug industry. The bipartisan legislation would require drug labels to disclose the original manufacturer and suppliers of key ingredients. This initiative follows criticism of manufacturers concealing drugmaking plant locations and suppliers, as well as reports of the FDA allowing troubled foreign drugmakers to continue selling generic medications. The Act seeks to empower patients, doctors, and pharmacists with more information about the drugs they use and prescribe, addressing the current lack of transparency where labels often only list distributors or repackagers. This push comes amid concerns that 90% of prescriptions in the U.S. are for generics, many manufactured overseas, with limited information available about their origins and safety records.

Key Entities & Roles

Key Player Opposition Context

Tommy Tuberville 50% Ron Johnson 50% Katie Britt 50% United States 60% Senate Special Committee on Aging 60% Food and Drug Administration ×270% Kirsten Gillibrand 70% Rick Scott ×280% ProPublica ×380% Clear Labels Act ×290%

Keywords

prescription drugs 100% drug labels 90% clear labels act 90% transparency 80% generic drugs 70% drug manufacturing 60% patient safety 60% drug ingredients 50% fda 50%

Sentiment Analysis

Positive

Score: 0.30

Source Transparency

Source

ProPublica

Political Lean

Center-Left (-0.40)

Far LeftCenterFar Right

Classification Confidence

90%

This article was automatically classified using rule-based analysis. The political bias score ranges from -1 (far left) to +1 (far right).

Topic Connections

Explore how the topics in this article connect to other news stories

No topic relationship data available yet. This graph will appear once topic relationships have been computed.

prescription drugs drug labels clear labels act transparency generic drugs drug manufacturing patient safety drug ingredients fda

Explore Full Topic Graph